These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 17442052

  • 1. Activation of recombinant human TRPV1 receptors expressed in SH-SY5Y human neuroblastoma cells increases [Ca(2+)](i), initiates neurotransmitter release and promotes delayed cell death.
    Lam PM, Hainsworth AH, Smith GD, Owen DE, Davies J, Lambert DG.
    J Neurochem; 2007 Aug; 102(3):801-11. PubMed ID: 17442052
    [Abstract] [Full Text] [Related]

  • 2. Characterization and comparison of recombinant human and rat TRPV1 receptors: effects of exo- and endocannabinoids.
    Lam PM, McDonald J, Lambert DG.
    Br J Anaesth; 2005 May; 94(5):649-56. PubMed ID: 15722382
    [Abstract] [Full Text] [Related]

  • 3. Pharmacology of capsaicin-, anandamide-, and N-arachidonoyl-dopamine-evoked cell death in a homogeneous transient receptor potential vanilloid subtype 1 receptor population.
    Davies JW, Hainsworth AH, Guerin CJ, Lambert DG.
    Br J Anaesth; 2010 May; 104(5):596-602. PubMed ID: 20354008
    [Abstract] [Full Text] [Related]

  • 4. TRPV1-mediated calcium signal couples with cannabinoid receptors and sodium-calcium exchangers in rat odontoblasts.
    Tsumura M, Sobhan U, Muramatsu T, Sato M, Ichikawa H, Sahara Y, Tazaki M, Shibukawa Y.
    Cell Calcium; 2012 Aug; 52(2):124-36. PubMed ID: 22656960
    [Abstract] [Full Text] [Related]

  • 5. Effect of olvanil and anandamide on vagal C-fiber subtypes in guinea pig lung.
    Lee MG, Weinreich D, Undem BJ.
    Br J Pharmacol; 2005 Oct; 146(4):596-603. PubMed ID: 16056239
    [Abstract] [Full Text] [Related]

  • 6. Activation of vanilloid receptor type I in the endoplasmic reticulum fails to activate store-operated Ca2+ entry.
    Wisnoskey BJ, Sinkins WG, Schilling WP.
    Biochem J; 2003 Jun 01; 372(Pt 2):517-28. PubMed ID: 12608892
    [Abstract] [Full Text] [Related]

  • 7. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide.
    Price TJ, Patwardhan A, Akopian AN, Hargreaves KM, Flores CM.
    Br J Pharmacol; 2004 Apr 01; 141(7):1118-30. PubMed ID: 15006899
    [Abstract] [Full Text] [Related]

  • 8. Effects of anandamide and noxious heat on intracellular calcium concentration in nociceptive drg neurons of rats.
    Fischbach T, Greffrath W, Nawrath H, Treede RD.
    J Neurophysiol; 2007 Aug 01; 98(2):929-38. PubMed ID: 17581853
    [Abstract] [Full Text] [Related]

  • 9. Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed.
    Poblete IM, Orliac ML, Briones R, Adler-Graschinsky E, Huidobro-Toro JP.
    J Physiol; 2005 Oct 15; 568(Pt 2):539-51. PubMed ID: 16081483
    [Abstract] [Full Text] [Related]

  • 10. Endovanilloids are potential activators of the trigeminovascular nocisensor complex.
    Dux M, Deák É, Tassi N, Sántha P, Jancsó G.
    J Headache Pain; 2016 Oct 15; 17():53. PubMed ID: 27189587
    [Abstract] [Full Text] [Related]

  • 11. Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors.
    Millns PJ, Chimenti M, Ali N, Ryland E, de Lago E, Fernandez-Ruiz J, Chapman V, Kendall DA.
    Eur J Neurosci; 2006 Dec 15; 24(12):3489-95. PubMed ID: 17229097
    [Abstract] [Full Text] [Related]

  • 12. Transient receptor potential vanilloid 1 agonists cause endoplasmic reticulum stress and cell death in human lung cells.
    Thomas KC, Sabnis AS, Johansen ME, Lanza DL, Moos PJ, Yost GS, Reilly CA.
    J Pharmacol Exp Ther; 2007 Jun 15; 321(3):830-8. PubMed ID: 17332266
    [Abstract] [Full Text] [Related]

  • 13. Pungency of TRPV1 agonists is directly correlated with kinetics of receptor activation and lipophilicity.
    Ursu D, Knopp K, Beattie RE, Liu B, Sher E.
    Eur J Pharmacol; 2010 Sep 01; 641(2-3):114-22. PubMed ID: 20576527
    [Abstract] [Full Text] [Related]

  • 14. N-palmitoyl-vanillamide (palvanil) is a non-pungent analogue of capsaicin with stronger desensitizing capability against the TRPV1 receptor and anti-hyperalgesic activity.
    De Petrocellis L, Guida F, Moriello AS, De Chiaro M, Piscitelli F, de Novellis V, Maione S, Di Marzo V.
    Pharmacol Res; 2011 Apr 01; 63(4):294-9. PubMed ID: 21215315
    [Abstract] [Full Text] [Related]

  • 15. Nonivamide, a capsaicin analog, increases dopamine and serotonin release in SH-SY5Y cells via a TRPV1-independent pathway.
    Rohm B, Holik AK, Somoza MM, Pignitter M, Zaunschirm M, Ley JP, Krammer GE, Somoza V.
    Mol Nutr Food Res; 2013 Nov 01; 57(11):2008-18. PubMed ID: 23929722
    [Abstract] [Full Text] [Related]

  • 16. A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1.
    Zhang N, Inan S, Cowan A, Sun R, Wang JM, Rogers TJ, Caterina M, Oppenheim JJ.
    Proc Natl Acad Sci U S A; 2005 Mar 22; 102(12):4536-41. PubMed ID: 15764707
    [Abstract] [Full Text] [Related]

  • 17. Up-regulation of TRPV1 in mononuclear cells of end-stage kidney disease patients increases susceptibility to N-arachidonoyl-dopamine (NADA)-induced cell death.
    Saunders CI, Fassett RG, Geraghty DP.
    Biochim Biophys Acta; 2009 Oct 22; 1792(10):1019-26. PubMed ID: 19619644
    [Abstract] [Full Text] [Related]

  • 18. TRPV1 channels facilitate glutamate transmission in the striatum.
    Musella A, De Chiara V, Rossi S, Prosperetti C, Bernardi G, Maccarrone M, Centonze D.
    Mol Cell Neurosci; 2009 Jan 22; 40(1):89-97. PubMed ID: 18930149
    [Abstract] [Full Text] [Related]

  • 19. Development of the first ultra-potent "capsaicinoid" agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential.
    Appendino G, De Petrocellis L, Trevisani M, Minassi A, Daddario N, Moriello AS, Gazzieri D, Ligresti A, Campi B, Fontana G, Pinna C, Geppetti P, Di Marzo V.
    J Pharmacol Exp Ther; 2005 Feb 22; 312(2):561-70. PubMed ID: 15356216
    [Abstract] [Full Text] [Related]

  • 20. Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology.
    Smart D, Jerman JC, Gunthorpe MJ, Brough SJ, Ranson J, Cairns W, Hayes PD, Randall AD, Davis JB.
    Eur J Pharmacol; 2001 Apr 06; 417(1-2):51-8. PubMed ID: 11301059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.